Senestech Inc Stock Price, News & Analysis

SenesTech (NASDAQ: SNES), a company specializing in fertility control solutions for rodent population management, has announced its participation in the upcoming Lytham Partners Spring 2025 Investor Conference. The virtual event will take place on May 29, 2025, featuring a webcast fireside chat at 3:30 p.m. ET. The company's management will also be available for one-on-one meetings with investors throughout the conference. Interested participants can access the webcast through the conference website or register for individual meetings with management through Lytham Partners.

SenesTech (NASDAQ: SNES) has announced it will release its first quarter 2025 financial results on Thursday, May 8, 2025, after the market close. The company will host a conference call the same day at 5:00 p.m. Eastern time to discuss the results for the period ended March 31, 2025.

Investors can join the conference call by dialing (844) 308-3351 or (412) 317-5407. A live webcast will be available through the company's Investor Relations website. A teleconference replay will be accessible for seven days, while the webcast replay will remain available for 90 days in the Investor Relations section.

SenesTech (Nasdaq: SNES) has expanded the deployment of its Evolve™ Rat Birth Control solution in Chicago's Wicker Park Bucktown Special Service Area. The program, implemented by the Wicker Park Bucktown Chamber of Commerce, involves installing bait boxes in neighborhood alleys to control rat populations without using harmful toxins or poisons.

The Chicago deployment follows significant urban implementations, including a rat contraceptive pilot program approved by the New York City Council in September, as well as deployments in Boston and Baltimore. The initiative aims to protect other animals and water supplies while effectively managing rodent populations.

Alice Howe, Special Service Area N. 33 Program Manager, is overseeing the program, while SenesTech's CEO Joel Fruendt reports positive early consumption rates and plans for expanding the deployment area with a second shipment already in progress. The company has also launched an informational website for local residents and business owners.

SenesTech (NASDAQ: SNES), a leader in fertility control solutions for rodent population management, has announced its participation in the Lytham Partners 2025 Industrials & Basic Materials Investor Summit. The company will engage in a virtual fireside chat on Tuesday, April 1, 2025, at 3:00 p.m. ET.

The event will be accessible through the conference website at lythampartners.com/ibmsummit25/ or directly via lythampartners.com/ibmsummit25/snes/. A replay option will be available through the same links. Additionally, interested parties can schedule one-on-one investor meetings following the event by reaching out to Lytham Partners representatives.

SenesTech (NASDAQ: SNES) reported strong Q4 2024 financial results, with revenue increasing 70% to $501,000 compared to Q4 2023. The company achieved a 60.9% gross profit margin, up from 43.7% in Q4 2023, while reducing operating expenses by 16%. Net loss decreased to $1.3 million from $1.7 million year-over-year.

The company's Evolve™ Rat product line contributed 52% of Q4 2024 revenue, while the newly launched Evolve™ Mouse accounted for 24%. E-commerce sales grew 206%, with successful launches on major platforms including Amazon and Walmart. The company has expanded internationally into 10 countries and secured municipal programs in several U.S. cities.

SenesTech announced new optimization initiatives expected to reduce expenses by $2 million annually, lowering the revenue threshold for cash flow breakeven from $12 million to approximately $7 million. The company's cash position stood at $1.3 million as of December 31, 2024, with an additional $2 million raised in Q1 2025 through ATM facility and warrant exercises.

SenesTech (NASDAQ: SNES) has announced warrant exercise agreements that will generate approximately $1.1 million in gross proceeds. The company, specializing in fertility control solutions for rodent populations, will allow the exercise of 374,718 outstanding warrants at a reduced price of $2.90 per share, down from the original $4.35.

As part of the transaction, SenesTech will issue new unregistered short-term warrants to purchase up to 1,498,872 shares at $2.90 per share, potentially generating an additional $4.3 million if fully exercised. These new warrants will be exercisable upon stockholder approval and expire 18 months thereafter. H.C. Wainwright is serving as the exclusive placement agent, with the transaction expected to close around March 11, 2025.